21 results
8-K
FUSN
Fusion Pharmaceuticals Inc
16 Oct 23
Fusion Pharmaceuticals Appoints Life Science Industry Leaders Jeremy Bender, Teresa Bitetti and David Meek to its Board of Directors
4:30pm
for purposes of attending Board meetings.
(d) On October 10, 2023, upon recommendation of the Nominating and Corporate Governance Committee
DEF 14A
n30wbzzfi bkt
27 Apr 21
Definitive proxy
4:02pm
8-K
ko2gbsse iimy2h
2 Apr 21
Departure of Directors or Certain Officers
8:00am
10-K
moc9u cewzj
25 Mar 21
Annual report
8:01am
8-K
43rg7vaxgd q89j
12 Feb 21
Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to
4:16pm
8-K
EX-99.1
vkvohyw k2i79
3 Nov 20
Fusion Pharmaceuticals Appoints Barbara Duncan as Chairperson of the Board of Directors
4:10pm
8-K
bx3bj8kvlqrbvks ur
3 Nov 20
Fusion Pharmaceuticals Appoints Barbara Duncan as Chairperson of the Board of Directors
4:10pm
10-Q
0inqaz9ku2c0wo4
11 Aug 20
Quarterly report
4:05pm
424B4
q9eqt0896
26 Jun 20
Prospectus supplement with pricing info
4:47pm
S-1/A
72t8 e231ldno7u6
22 Jun 20
IPO registration (amended)
6:16am
S-1
xdu7levezole0t
5 Jun 20
IPO registration
4:16pm
DRS/A
xbhsidbewpd
14 May 20
Draft registration statement (amended)
12:00am